Deuterium-enriched capecitabine

Details Deuterium-enriched capecitabine Deuterium-enriched capecitabine

2008-08-21

2010-11-30

Lewis, Patrick T (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S043000

Reexamination Certificate

active

07842675

ABSTRACT:
The present application describes deuterium-enriched capecitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

REFERENCES:
patent: 5472949 (1995-12-01), Arasaki et al.
patent: 26325 (1995-10-01), None
Schuller et al. Cancer Chemother. Pharmacol. (2000), vol. 45, pp. 291-297.
Kushner, D.J.; Pharmacological Uses and Perspectives of Heavy Water and Deuterated Compounds; Canadian Journal of Physiology and Pharmacology 1999, 77(2), 79-88.

Affiliated with

Also associated with

Rating

Deuterium-enriched capecitabine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deuterium-enriched capecitabine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deuterium-enriched capecitabine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4205110